XML 41 R18.htm IDEA: XBRL DOCUMENT v3.10.0.1
Note 12 - Stock-based Compensation
6 Months Ended
Jun. 30, 2018
Notes to Financial Statements  
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]
12.
Stock-Based Compensation
 
(a)
Stock-Based Compensation Expense
 
Total stock-based compensation expense in the Company’s unaudited Consolidated Statements of Income related to the Company’s long-term incentive award plans was as follows
(in thousands)
:
 
 
 
Three Months Ended June
30,
 
Six Months Ended

June 30,
 
 
2018
 
2017
 
2018
 
2017
Cost of services-compensation
 
$
1,673
 
 
$
1,462
 
 
$
4,236
 
 
$
3,503
 
Selling, general and administrative
 
 
3,041
 
 
 
2,532
 
 
 
9,972
 
 
 
5,877
 
Total
 
$
4,714
 
 
$
3,994
 
 
$
14,208
 
 
$
9,380
 
 
(b)
Stock Options
 
Stock-based compensation expense related to stock options was approximately
$2.1
million and
$1.7
million for the
three
months ended
June 30, 2018
and
2017,
respectively. Stock-based compensation expense related to stock options was approximately
$6.1
million and
$3.9
million for the
six
months ended
June 30, 2018
and
2017,
respectively.
 
Presented below is a summary of stock option activity for the
six
months ended
June 30, 2018 (
in thousands except for weighted average exercise price and weighted average remaining contractual terms
):
 
 
 
Number
of
Options
 
Weighted

Average

Exercise

Price
 
Weighted

Average

Remaining

Contractual

Terms
 
Aggregate

Intrinsic

Value
Outstanding balance at December 31, 2017
 
 
5,554
 
 
$
17.35
 
 
 
 
 
 
 
 
 
Granted
 
 
1,010
 
 
 
19.58
 
 
 
 
 
 
 
 
 
Exercised
 
 
(151
)
 
 
15.81
 
 
 
 
 
 
 
 
 
Forfeitures
 
 
(26
)
 
 
16.43
 
 
 
 
 
 
 
 
 
Expired
 
 
(27
)
 
 
22.14
 
 
 
 
 
 
 
 
 
Outstanding balance at June 30, 2018
 
 
6,360
 
 
 
17.78
 
 
 
5.37
 
 
 
26,785
 
Expected to vest at June 30, 2018
 
 
1,633
 
 
 
17.68
 
 
 
8.00
 
 
 
6,449
 
Exercisable at June 30, 2018
 
 
3,877
 
 
$
17.87
 
 
 
3.72
 
 
 
16,929
 
 
During the
three
months ended
June 30, 2018
and
2017,
the Company issued
87,230
and
132,128
shares, respectively, of the Company’s common stock upon the exercise of outstanding stock options and received proceeds of
$2.2
million and
$2.0
million, respectively. The total intrinsic value of stock options exercised during the
three
months ended
June 30, 2018
and
2017
was
$0.8
million and
$0.6
million, respectively. During the
six
months ended
June 30, 2018
and
2017,
the Company issued
151,034
and
132,805
shares, respectively, of the Company’s common stock upon the exercise of outstanding stock options and received proceeds of
$2.4
million and
$2.0
million, respectively. The total intrinsic value of stock options exercised during the
six
months ended
June 30, 2018
and
2017
was
$0.8
million and
$0.6
million, respectively.
 
As of
June 30, 2018,
there was approximately
$9.6
million of total unrecognized compensation cost related to stock options outstanding, which is expected to be recognized over a weighted average period of
2.3
years.
 
The weighted-average grant date fair value per share of the stock options granted during the
six
months ended
June 30, 2018
and
2017
was
$7.52
and
$7.73,
respectively. HMS estimated the fair value of each stock option grant on the date of grant using a Black-Scholes option pricing model and weighted–average assumptions set forth in the following table:
 
 
 
Six Months Ended
June 30,
 
 
2018
 
2017
Expected dividend yield
 
 
0%
 
 
0%
Risk-free interest rate
 
 
2.68%
 
 
1.74%
Expected volatility
 
 
42.43%
 
 
44.23%
Expected life (years)
 
 
6.00
 
 
 
5.00
 
 
The total tax benefits recognized on stock-based compensation for the
three
and
six
months ended
June 30, 2018
and
2017
was
$2.5
million and
$3.6
million, respectively.
 
(c)
Restricted Stock Units
 
Stock-based compensation expense related to restricted stock units was approximately
$2.6
million and
$2.2
million for the
three
months ended
June 30, 2018
and
2017,
respectively. Stock-based compensation expense related to restricted stock units was approximately
$8.1
million and
$5.5
million for the
six
months ended
June 30, 2018
and
2017,
respectively.
 
Presented below is a summary of restricted stock units activity for the
six
months ended
June 30, 2018
(in thousands, except for weighted average grant date fair value per unit):
 
 
 
Number of

Units
 
Weighted Average

Grant Date Fair

Value per Unit
Outstanding balance at December 31, 2017
 
 
1,346
 
 
$
17.65
 
Granted
 
 
761
 
 
 
16.72
 
Vesting of restricted stock units, net of units withheld for taxes
 
 
(364
)
 
 
16.93
 
Units withheld for taxes
 
 
(161
)
 
 
16.93
 
Forfeitures
 
 
(26
)
 
 
16.89
 
Outstanding balance at June 30, 2018
 
 
1,556
 
 
$
19.98
 
 
For the
three
months ended
June 30, 2018
and
2017,
HMS granted
62,259
and
536,023
restricted stock units, respectively, with an aggregate fair market value of
$0.9
million and
$10.2
million, respectively. For the
six
months ended
June 30, 2018
and
2017,
HMS granted
761,083
and
539,657
restricted stock units, respectively, with an aggregate fair market value of
$12.7
million and
$10.3
million, respectively.
 
As of
June 30, 2018,
1,330,734
restricted stock units remained unvested and there was approximately
$13.9
million of unrecognized compensation cost related to restricted stock units, which is expected to be recognized over a weighted average vesting period of
1.38
years.